Top Story

‘Smarter and stronger’ T cells offer hope for more effective, less toxic cancer therapy

‘Smarter and stronger’ T cells offer hope for more effective, less toxic cancer therapy
August 18, 2019

New targets, treatment strategies create ‘exciting time’ in triple-negative breast cancer

August 17, 2019
Although breast cancer mortality has declined by 40% over the past several decades, more than 40,000 women will die of the disease this year, according to SEER data. …
In the Journals

Teratoma linked to higher cumulative incidence of germ cell tumor-related death

August 16, 2019
Teratoma appeared associated with a higher cumulative incidence of disease-related death among men with nonseminomatous germ cell primary tumors, according to results of…
FDA News

FDA approves Inrebic for myelofibrosis

August 16, 2019
The FDA today approved fedratinib for the treatment of adults with intermediate-2 or high-risk primary or secondary myelofibrosis. “Myelofibrosis can cause…
In the Journals

Avoid skin markings in dermoscopic images for analysis, training by convolutional neural networks

August 16, 2019
Melanoma probability scores increased due to standard skin markings from surgical ink and were associated with a significant reduction in the specificity of a…
More Headlines »

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease…
More »
Meeting News

VIDEO: Tumor size, node status, age affect risk for breast cancer mortality

July 10, 2019
More »
Resource Centers
Discoveries from ASCO: Breast Cancer

Discoveries from ASCO: Breast Cancer


Ace the Case: A 9-Year-Old Girl With Bruising, Fatigue, Left Hip Pain, and Intermittent Fever for 2 Weeks

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of childhood leukemia.
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next